Advertisement
Screener

Unity Biotechnology, Inc. Net Income

Unity Biotechnology, Inc. Net Income

Unity Biotechnology, Inc. reported Net Income of -$7.30 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-22.

Financial Statements › Income Statement

us-gaap:NetIncomeLoss · last filed 2025-04-22

  • Unity Biotechnology, Inc. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$7.30M.
  • Unity Biotechnology, Inc. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$8.44M.
  • Unity Biotechnology, Inc. net income (loss) attributable to parent for the quarter ending 2024-09-30 was -$6.48M.
  • Unity Biotechnology, Inc. net income (loss) attributable to parent for the quarter ending 2024-06-30 was -$5.28M.
  • Unity Biotechnology, Inc. net income (loss) attributable to parent for fiscal 2024 was -$25.99M.
  • Unity Biotechnology, Inc. net income (loss) attributable to parent for fiscal 2023 was -$39.86M.
  • Unity Biotechnology, Inc. net income (loss) attributable to parent for fiscal 2022 was -$44.47M.
  • Unity Biotechnology, Inc. net income (loss) attributable to parent for fiscal 2021 was -$60.73M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 9 month as first filedNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2025-03-31-$7.30M
10-Q · filed 2025-04-22
-$15.74M
derived: sum of 2 quarters · filed 2025-04-22
-$22.22M
derived: sum of 3 quarters · filed 2025-04-22
-$27.50M
derived: sum of 4 quarters · filed 2025-04-22
2024-12-31-$8.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
-$14.92M
derived: sum of 2 quarters · filed 2025-03-07
-$20.20M
derived: sum of 3 quarters · filed 2025-03-07
-$25.99M
10-K · filed 2025-03-07
2024-09-30-$6.48M
10-Q · filed 2024-11-04
-$11.76M
derived: sum of 2 quarters · filed 2024-11-04
-$17.55M
10-Q · filed 2024-11-04
-$21.89M
derived: sum of 4 quarters · filed 2025-04-22
2024-06-30-$5.28M
10-Q · filed 2024-11-04
-$11.07M
10-Q · filed 2024-08-06
-$15.41M
derived: sum of 3 quarters · filed 2025-04-22
-$30.19M
derived: sum of 4 quarters · filed 2025-04-22
2024-03-31-$5.79M
10-Q · filed 2025-04-22
-$10.13M
derived: sum of 2 quarters · filed 2025-04-22
-$24.91M
derived: sum of 3 quarters · filed 2025-04-22
-$40.37M
derived: sum of 4 quarters · filed 2025-04-22
2023-12-31-$4.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
-$19.12M
derived: sum of 2 quarters · filed 2025-03-07
-$34.58M
derived: sum of 3 quarters · filed 2025-03-07
-$39.86M
10-K · filed 2025-03-07
2023-09-30-$14.78M
10-Q · filed 2024-11-04
-$15.29M
10-Q · filed 2023-11-13
-$30.24M
derived: sum of 2 quarters · filed 2024-11-04
-$35.52M
10-Q · filed 2024-11-04
-$38.36M
10-Q · filed 2023-11-13
-$42.94M
derived: sum of 4 quarters · filed 2025-03-07
2023-06-30-$15.46M
10-Q · filed 2024-11-04
-$12.21M
10-Q · filed 2023-08-08
-$20.73M
10-Q · filed 2024-08-06
-$23.07M
10-Q · filed 2023-08-08
-$28.16M
derived: sum of 3 quarters · filed 2025-03-07
-$33.15M
derived: sum of 4 quarters · filed 2025-03-07
2023-03-31-$5.28M
10-Q · filed 2024-11-04
-$10.87M
10-Q · filed 2023-05-09
-$12.70M
derived: sum of 2 quarters · filed 2025-03-07
-$17.70M
derived: sum of 3 quarters · filed 2025-03-07
-$30.84M
derived: sum of 4 quarters · filed 2025-03-07
2022-12-31-$7.42M
derived: 10-K 12 month − 10-K 9 month · filed 2025-03-07
-$12.42M
derived: sum of 2 quarters · filed 2025-03-07
-$25.56M
derived: sum of 3 quarters · filed 2025-03-07
-$44.47M
10-K · filed 2025-03-07
-$59.93M
10-K · filed 2023-03-15
2022-09-30-$5.00M
10-K · filed 2024-04-15
-$13.71M
10-Q · filed 2022-11-08
-$18.13M
derived: sum of 2 quarters · filed 2024-04-15
-$37.05M
10-K · filed 2024-04-15
-$45.76M
10-Q · filed 2022-11-08
-$47.74M
derived: sum of 4 quarters · filed 2024-04-15
2022-06-30-$13.14M
10-Q · filed 2023-11-13
-$32.05M
10-Q · filed 2023-08-08
-$42.74M
derived: sum of 3 quarters · filed 2024-04-15
-$59.20M
derived: sum of 4 quarters · filed 2024-04-15
2022-03-31-$18.91M
10-Q · filed 2023-11-13
-$29.61M
derived: sum of 2 quarters · filed 2024-04-15
-$46.06M
derived: sum of 3 quarters · filed 2024-04-15
-$63.88M
derived: sum of 4 quarters · filed 2024-04-15
2021-12-31-$10.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15
-$27.14M
derived: sum of 2 quarters · filed 2024-04-15
-$44.97M
derived: sum of 3 quarters · filed 2024-04-15
-$60.73M
10-K · filed 2024-04-15
2021-09-30-$16.45M
10-Q · filed 2022-11-08
-$34.28M
derived: sum of 2 quarters · filed 2022-11-08
-$50.03M
10-Q · filed 2022-11-08
-$69.62M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$17.83M
10-Q · filed 2022-11-08
-$33.58M
10-Q · filed 2022-08-12
-$53.17M
derived: sum of 3 quarters · filed 2022-11-08
-$80.72M
derived: sum of 4 quarters · filed 2022-11-08
2021-03-31-$15.76M
10-Q · filed 2022-11-08
-$35.34M
derived: sum of 2 quarters · filed 2022-11-08
-$62.90M
derived: sum of 3 quarters · filed 2022-11-08
-$81.56M
derived: sum of 4 quarters · filed 2022-11-08
2020-12-31-$19.59M
10-K · filed 2021-03-23
-$47.14M
derived: sum of 2 quarters · filed 2021-11-10
-$65.81M
derived: sum of 3 quarters · filed 2021-11-10
-$93.84M
10-K · filed 2023-03-15
2020-09-30-$27.55M
10-Q · filed 2021-11-10
-$46.22M
derived: sum of 2 quarters · filed 2021-11-10
-$74.26M
10-Q · filed 2021-11-10
-$92.28M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$18.67M
10-Q · filed 2021-11-10
-$46.70M
10-Q · filed 2021-08-10
-$64.73M
derived: sum of 3 quarters · filed 2021-11-10
-$86.44M
derived: sum of 4 quarters · filed 2021-11-10
2020-03-31-$28.04M
10-Q · filed 2021-11-10
-$46.06M
derived: sum of 2 quarters · filed 2021-11-10
-$67.78M
derived: sum of 3 quarters · filed 2021-11-10
-$91.45M
derived: sum of 4 quarters · filed 2021-11-10
2019-12-31-$18.03M
10-K · filed 2021-03-23
-$39.74M
derived: sum of 2 quarters · filed 2021-03-23
-$63.41M
derived: sum of 3 quarters · filed 2021-03-23
-$82.18M
10-K · filed 2022-03-15
2019-09-30-$21.71M
10-K · filed 2021-03-23
-$45.38M
derived: sum of 2 quarters · filed 2021-03-23
-$64.15M
10-Q · filed 2020-11-04
-$86.07M
derived: sum of 4 quarters · filed 2021-03-23
2019-06-30-$23.67M
10-K · filed 2021-03-23
-$42.44M
10-Q · filed 2020-07-31
-$64.36M
derived: sum of 3 quarters · filed 2021-03-23
-$82.70M
derived: sum of 4 quarters · filed 2021-03-23
2019-03-31-$18.77M
10-K · filed 2021-03-23
-$40.68M
derived: sum of 2 quarters · filed 2021-03-23
-$59.03M
derived: sum of 3 quarters · filed 2021-03-23
-$79.03M
derived: sum of 4 quarters · filed 2021-03-23
2018-12-31-$21.92M
10-K · filed 2020-03-11
-$40.26M
derived: sum of 2 quarters · filed 2020-03-11
-$60.27M
derived: sum of 3 quarters · filed 2020-03-11
-$76.40M
10-K · filed 2021-03-23
2018-09-30-$18.35M
10-K · filed 2020-03-11
-$38.35M
derived: sum of 2 quarters · filed 2020-03-11
-$54.48M
10-Q · filed 2019-11-06
-$67.03M
derived: sum of 4 quarters · filed 2020-03-11
2018-06-30-$20.00M
10-K · filed 2020-03-11
-$36.13M
10-Q · filed 2019-08-07
-$48.68M
derived: sum of 3 quarters · filed 2020-03-11
-$60.43M
derived: sum of 4 quarters · filed 2020-03-11
2018-03-31-$16.13M
10-K · filed 2020-03-11
-$28.68M
derived: sum of 2 quarters · filed 2020-03-11
-$40.43M
derived: sum of 3 quarters · filed 2020-03-11
-$51.85M
derived: sum of 4 quarters · filed 2020-03-11
2017-12-31-$12.54M
10-K · filed 2019-03-06
-$24.29M
derived: sum of 2 quarters · filed 2019-03-06
-$35.72M
derived: sum of 3 quarters · filed 2019-03-06
-$44.66M
10-K · filed 2020-03-11
2017-09-30-$11.75M
10-K · filed 2019-03-06
-$23.18M
derived: sum of 2 quarters · filed 2019-03-06
-$32.11M
10-Q · filed 2018-11-07
2017-06-30-$11.43M
10-K · filed 2019-03-06
-$20.36M
10-Q · filed 2018-08-09
2017-03-31-$8.93M
10-K · filed 2019-03-06
2016-12-31-$30.40M
10-K · filed 2019-03-06